Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KGET |
---|---|---|
10:13 ET | 1000 | 1E-06 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Calipharms Inc | 13.0K | 0.0x | --- |
Bioelife Corp | 10.0 | 0.0x | --- |
Rapid Therapeutic Science Laboratories Inc | 19.0K | 0.2x | --- |
Green and Hill Industries Inc | 100.0 | 0.0x | --- |
Northstar Global Business Services Inc | 40.0 | 0.0x | --- |
Bangi Inc | 5.6K | 0.0x | --- |
CaliPharms Inc is a developmental stage acquisition company. The Company is focused on acquiring, merging, and joint venturing with legally permitted fully operational marijuana-cannabis businesses. The Company is seeking acquisitions in medical marijuana-cannabis cultivation. The Company focuses on the medical-grade marijuana-cannabis within the State of California. The Company is also expanding into other sectors that support the legalized marijuana industry.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.0K |
---|---|
Revenue (TTM) | $112.5K |
Shares Outstanding | 13.0B |
Calipharms Inc does not pay a dividend. | |
Beta | --- |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,069.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.